Comment: reasons for early abacavir discontinuation in HIV-infected patients

MLA

Parra-Ruiz, Jorge, et al. “Comment: Reasons for Early Abacavir Discontinuation in HIV-Infected Patients.” The Annals of Pharmacotherapy, vol. 38, no. 3, Mar. 2004, pp. 512–13. EBSCOhost, https://doi.org/10.1345/aph.1C523a.

APA

Parra-Ruiz, J., Martínez-Ramírez, M., Muñoz-Medina, L., Serrano-Falcón, C., & Hernández-Quero, J. (2004). Comment: reasons for early abacavir discontinuation in HIV-infected patients. The Annals of Pharmacotherapy, 38(3), 512–513. https://doi.org/10.1345/aph.1C523a

Chicago

Parra-Ruiz, Jorge, Mariela Martínez-Ramírez, Leopoldo Muñoz-Medina, Cristina Serrano-Falcón, and José Hernández-Quero. 2004. “Comment: Reasons for Early Abacavir Discontinuation in HIV-Infected Patients.” The Annals of Pharmacotherapy 38 (3): 512–13. doi:10.1345/aph.1C523a.